Kyverna Therapeutics Inc.

2.16
0.03 (1.41%)
At close: Apr 24, 2025, 3:59 PM
2.04
-5.56%
Pre-market: Apr 25, 2025, 08:47 AM EDT

Kyverna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
-127.48M -110.66M -91.63M -75.92M -60.37M -48.2M -32.73M -19.64M -8.5M
2.13M 2.03M 1.91M 1.79M 1.71M 1.62M 1.18M 768K 374K
8.36M 7.76M 4.87M 4.03M 2.22M 1.77M 1.25M 805K 337K
2.05M -5.25M 2.49M -4.01M -697K 991K -1.87M -1.87M -282K
227K 2.23M 278K 2.31M 2.17M 2.13M 1.24M 803K 419K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
2.79M 3.77M 6.95M 3.07M 3.42M 1.1M -2.27M -2.79M -1.31M
-114.25M -95.75M -79.39M -66.48M -52.41M -42.66M -31.53M -20.27M -8.82M
-2.21M -2.01M -2.16M -1.14M -621K -299K -43K -40K -12K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-490M -363.74M -280.08M -200.18M -54.85M -55.3M -1.44M -1.44M -1.44M
325.87M 201.87M 69M 56M 46.68M 30.28M 30.28M 30.28M 16.6M
-116.91M -84.89M -90.32M -90.32M 45.7M 28.84M 28.84M 28.84M 15.16M
-160.9M -158.44M -213.24M -145.32M -8.79M -25.32M 28.8M 28.8M 15.15M
-956K -928K -891K -844K -781K -707K -502K -313K -145K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-3.1M -4.35M -4.29M 21.14M 24.06M 25.32M 25.16M 67K 43K
337.11M 335.89M 370.84M 396.31M 58.12M 59.45M 24.66M -246K -102K
61.96M 81.7M 78.2M 184.51M -3.08M -8.53M 21.93M 8.28M 6.23M
-116.45M -97.76M -81.56M -67.61M -53.03M -42.96M -31.57M -20.32M -8.83M